HRT Financial’s YD Bio Ltd YDES Stock Holding History

HRT Financial’s Portfolio YDES Stock Details YDES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31,819	Closed	-$619K	–	4344
2025 Q3	$619K	Buy	+31,819	New	+$553K	﹤0.01%	1770

Other funds holding YDES

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial's YDES Position: Q4 2025 in Review

HRT Financial sold out of YD Bio Ltd (YDES) in Q4 2025, closing a stake of 31,819 shares — an estimated $619K sold.

HRT Financial first reported a position in YDES in Q3 2025 and held it in 1 quarter. The position peaked at $619K in Q3 2025. 10 funds tracked by Wall St. Rank hold YDES as of Q4 2025.

HRT Financial reported no remaining YD Bio Ltd position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 31,819 YD Bio Ltd shares in Q4 2025, an estimated $619K.
HRT Financial first reported a position in YD Bio Ltd in Q3 2025 and held it in 1 quarter.
HRT Financial's YD Bio Ltd position peaked at $619K in Q3 2025.
10 funds tracked by Wall St. Rank held YD Bio Ltd as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.